Search results for " Pharmacy"

showing 10 items of 365 documents

Population Pharmacokinetics of Palbociclib in aReal-World Situation

2021

Palbociclib is an oral cyclin-dependent kinase inhibitor that is used in combination with aromatase inhibitors in the treatment of postmenopausal women with metastatic breast cancer. Its metabolism profile is associated with an important interpatient variability. We performed a population pharmacokinetics study of palbociclib in women routinely followed in a cancer center. One hundred and fifty-one samples were analyzed. The sampling times after administration ranged from 0.9 to 75 h and the samples were taken between 1 and 21 days after the beginning of the palbociclib cycle. Palbociclib was determined using a validated mass spectrometry method. The best model that described the concentrat…

Oncologymedicine.medical_specialtypalbociclibPharmaceutical ScienceRenal functionlcsh:Medicinelcsh:RS1-441Population pharmacokineticsAbsorption (skin)Palbociclib030226 pharmacology & pharmacyArticlelcsh:Pharmacy and materia medica03 medical and health sciences0302 clinical medicineLag timepopulation pharmacokineticsInternal medicineDrug Discoverymedicinereal-world situationDosingPostmenopausal womenbusiness.industrylcsh:Rmedicine.diseaseMetastatic breast cancer030220 oncology & carcinogenesisMolecular MedicinebusinessPharmaceuticals
researchProduct

Azulene as a biphenyl mimetic in orexin/hypocretin receptor agonists

2023

Azulene is a rare ring structure in drugs, and we investigated whether it could be used as a biphenyl mimetic in known orexin receptor agonist Nag 26, which is binding to both orexin receptors OX1 and OX2 with preference towards OX2. The most potent azulene-based compound was identified as an OX1 orexin receptor agonist (pEC50 = 5.79 +/- 0.07, maximum response = 81 +/- 8% (s.e.m. of five independent experiments) of the maximum response to orexin-A in Ca2+ elevation assay). However, the azulene ring and the biphenyl scaffold are not identical in their spatial shape and electron distribution, and their derivatives may adopt different binding modes in the binding site. Peer reviewed

Orexin receptorSulfonamidesazuleneOrganic ChemistryClinical BiochemistryAgonistPharmaceutical ScienceMedicinal chemistryBiochemistrylääkekemia317 Pharmacymedicinal chemistrysulfonamidesDrug DiscoveryatsuleeniMolecular Medicine1182 Biochemistry cell and molecular biologyAzulene3111 BiomedicineagonistMolecular Biologyorexin receptor
researchProduct

Significance of Various Enzymes in the Control of Mutagenic and Carcinogenic Metabolites Derived from Aromatic Structures

1984

One important early contribution to the control of chemical carcinogenesis is provided by the enzyme pattern responsible for the generation and disposition of reactive metabolites. Especially well studied is the important group of enzymes responsible for the control of reactive epoxides. Many natural as well as man-made foreign compounds, including Pharmaceuticals, possess olefinic or aromatic double bonds. Such compounds can be transformed to epoxides by microsomal monooxygenases present in very many mammalian organs. By virtue of their electrophilic reactivity such epoxides may spontaneously react with nucleophilic centers in the cell and thus covalently bind to DNA, RNA, and protein. Su…

Oxidoreductases Acting on CH-CH Group Donors040301 veterinary sciencesEpoxideToxicology030226 pharmacology & pharmacyMixed Function OxygenasesPathology and Forensic Medicine0403 veterinary scienceToxicology03 medical and health scienceschemistry.chemical_compoundCytosol0302 clinical medicineBiosynthesisAnimalsPolycyclic CompoundsMolecular BiologyCarcinogenGlutathione TransferaseEpoxide Hydrolaseschemistry.chemical_classification04 agricultural and veterinary sciencesCell BiologyMetabolismMonooxygenaseEnzymesAlcohol OxidoreductasesKineticsEnzymechemistryBiochemistryEpoxide HydrolasesCarcinogensMicrosomes LiverOxidoreductasesDNAMutagensToxicologic Pathology
researchProduct

Six years of progress in the oral biopharmaceutics area - A summary from the IMI OrBiTo project.

2020

OrBiTo was a precompetitive collaboration focused on the development of the next generation of Oral Biopharmaceutics Tools. The consortium included world leading scientists from nine universities, one regulatory agency, one non-profit research organisation, three small/medium sized specialist technology companies together with thirteen pharmaceutical companies. The goal of the OrBiTo project was to deliver a framework for rational application of predictive biopharmaceutics tools for oral drug delivery. This goal was achieved through novel prospective investigations to define new methodologies or refinement of existing tools. Extensive validation has been performed of novel and existing biop…

PBPKEngineeringBest practicePharmaceutical ScienceAdministration Oral02 engineering and technology030226 pharmacology & pharmacyPermeabilityBiopharmaceutics03 medical and health sciences0302 clinical medicineDrug Delivery SystemsGastrointestinal drug absorptionDrug DevelopmentAnimalsHumansProspective StudiesIVIVCDrug absorptionbusiness.industryBiopharmaceuticsIndustrial researchGeneral Medicine021001 nanoscience & nanotechnologyGastrointestinal TractEngineering managementDrug developmentIntestinal AbsorptionPharmaceutical PreparationsNew product developmentRegulatory agency0210 nano-technologybusinessDissolutionOral retinoidBiotechnologyEuropean journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
researchProduct

Predicting Lung Deposition of Extrafine Inhaled Corticosteroid-Containing Fixed Combinations in Patients with Chronic Obstructive Pulmonary Disease U…

2021

Background: Functional respiratory imaging (FRI) is a computational fluid dynamics-based technique using three-dimensional models of human lungs and formulation profiles to simulate aerosol deposition. Methods: FRI was used to evaluate lung deposition of extrafine beclomethasone dipropionate (BDP)/formoterol fumarate (FF)/glycopyrronium bromide (GB) and extrafine BDP/FF delivered through pressurized metered dose inhalers and to compare results with reference gamma scintigraphy data. FRI combined high-resolution computed tomography scans of 20 patients with moderate-to-severe chronic obstructive pulmonary disease (mean forced expiratory volume in 1 second 42% predicted) with in silico comput…

PathologyRespiratory SystemPharmaceutical ScienceINHALATION030226 pharmacology & pharmacyPulmonary Disease Chronic Obstructive0302 clinical medicineAdrenal Cortex HormonesFormoterol FumaratePharmacology (medical)1102 Cardiorespiratory Medicine and Haematologycombination drugLungBRONCHODILATOROriginal Researchlung depositionBeclomethasonerespiratory systemDrug CombinationsTreatment OutcomeCorticosteroid1115 Pharmacology and Pharmaceutical SciencesPMDILife Sciences & BiomedicineCombination drugPulmonary and Respiratory Medicinemedicine.medical_specialtyLung depositionextrafinemedicine.drug_classIn silicoPulmonary diseaseSettore MED/10 - Malattie Dell'Apparato Respiratorioinhaled corticosteroid03 medical and health sciencespressurized metered-dose inhalerAdministration InhalationmedicineHumansIn patientComputer SimulationSMALL AIRWAYScombination drug extrafine functional respiratory imaging inhaled corticosteroid lung deposition pressurized metered-dose inhalerScience & TechnologyRespiratory imagingbusiness.industryDYSFUNCTION030228 respiratory systemASTHMAfunctional respiratory imagingbusiness
researchProduct

Osteoporosis: Economic Burden of Disease in Italy.

2020

Background and Objective: Today, osteoporosis is the most common bone disease and an important public health problem in all developed countries. The objective of this study was to estimate the costs associated with the management and treatment of osteoporosis in order to assess the economic burden in Italy for 2017, in terms of direct medical costs and social security costs. Methods: A cost of illness model was developed to estimate the average cost per year sustained by the NHS (National Health Service) and Social Security System in Italy. A systematic literature review was performed to obtain epidemiological, direct and indirect costs parameters where available. Hospitalisation costs were…

Patient Discharge.Malemedicine.medical_specialtySettore SECS-P/06accountingalliedhealth030204 cardiovascular system & hematology030226 pharmacology & pharmacyState MedicineServizio Sanitario Nazionale03 medical and health sciencesIndirect costs0302 clinical medicineCost of IllnessInternational Classification of DiseasesEnvironmental healthEpidemiologyInternational Classification of DiseasemedicineHumansPharmacology (medical)health care economics and organizationsAverage costAgedPensionbusiness.industryPublic healthOsteoporosieconomicsAged; Female; Health Care Costs; Hospitalization; Humans; International Classification of Diseases; Italy; Male; Middle Aged; Osteoporosis; Patient Discharge; State Medicine; Cost of IllnessGeneral MedicineHealth Care Costsosteoporosi Italia Servizio Sanitario NazionaleMiddle AgedItaliaPatient DischargeHealth Care CostSocial securityHospitalizationSystematic reviewItalySettore MED/42OsteoporosisFemalebusinessDeveloped countryHumanClinical drug investigation
researchProduct

DD-008 Monitoring of the adherence to therapies for the treatment of pulmonary hypertension

2015

Background Adherence to the treatment for pulmonary arterial hypertension (PAH) is an important aspect of chronic disease management to improve the efficacy of treatment. 1 Purpose The study aimed to evaluate adherence to long-term drug treatments for PAH. Material and methods From 01/01/2010 to 04/01/2014 a retrospective analysis was done on therapeutic plans and prescriptions related to patients in treatment for at least one year by the Pneumology Unit. Items dispensed by the Clinical Pharmacist were analysed through data entered into the database F file. Mean therapeutic adherence, according to the literature, 2 was calculated using the "pharmacy-refill" method: days of dispensed treatme…

Pediatricsmedicine.medical_specialtyAmbrisentanSildenafilbusiness.industrymedicine.diseasePulmonary hypertensionBosentanClinical pharmacychemistry.chemical_compoundTherapeutic AdherenceAcquired immunodeficiency syndrome (AIDS)chemistrymedicineGeneral Pharmacology Toxicology and PharmaceuticsMedical prescriptionbusinessmedicine.drugEuropean Journal of Hospital Pharmacy
researchProduct

PS-110 Extent and diversity of day-to-day clinical pharmacists’ interventions in hospitals

2015

Background Clinical pharmacy services (CPS) are known to improve medication safety and patients’ clinical outcome. However, in the majority of the European countries their implementation is low and there are no nationwide reports about the nature of clinical pharmacists’ interventions (CPIs) in European hospitals outside the UK. Purpose To evaluate both the extent and diversity of data about national hospital CPIs nationwide. Material and methods Datasets from ADKA-DokuPIK, an anonymous and voluntary German database for the documentation of hospital CPIs with >500 registered users, which were entered between 01/2009 and 12/2012, were analysed descriptively. Results In total, 27,610 CPIs wer…

Pediatricsmedicine.medical_specialtybusiness.industryAcceptance ratePsychological interventionAlternative medicineConflict of interestmedicine.diseaseClinical pharmacyEmergency medicineMedicineGeneral Pharmacology Toxicology and PharmaceuticsDay to daybusinessStrokeDiversity (business)European Journal of Hospital Pharmacy
researchProduct

Comparison of free software platforms for the calculation of the 90% confidence interval of f2 similarity factor by bootstrap analysis

2020

Abstract Introduction The calculation of the 90% confidence interval of f2 based on the bootstrap methodology has been proposed and accepted by the main regulatory authorities when the dissolution data shows excessive variability. Different free software platforms allow the calculation of the 90% CI of f2 by means of bootstrapping. Their use in regulatory submissions is growing, but divergent results have been observed between the available software platforms. Therefore, the objective of this work is to analyze the characteristics of these software platforms and evaluate their results. Methods and materials Highly variable in vitro dissolution data from two products were selected. Three dif…

Percentilebusiness.industryPharmaceutical ScienceValue (computer science)02 engineering and technology021001 nanoscience & nanotechnology030226 pharmacology & pharmacyConfidence interval03 medical and health sciencesVariable (computer science)0302 clinical medicineSoftwareBootstrapping (electronics)Similarity (network science)StatisticsTruncation (statistics)0210 nano-technologybusinessMathematicsEuropean Journal of Pharmaceutical Sciences
researchProduct

Biowaiver Monographs for Immediate-Release Solid Oral Dosage Forms: Folic Acid.

2018

This work presents a review of literature and experimental data relevant to the possibility of waiving pharmacokinetic bioequivalence studies in human volunteers for approval of immediate-release solid oral pharmaceutical forms containing folic acid as the single active pharmaceutical ingredient. For dosage forms containing 5 mg folic acid, the highest dose strength on the World Health Organization Essential Medicines List, the dose/solubility ratio calculated from solubility studies was higher than 250 mL, corresponding to a classification as "not highly soluble." Small, physiological doses of folic acid (≤320 μg) seem to be absorbed completely via active transport, but permeability data f…

Pharmaceutical ScienceAdministration OralBiological AvailabilityBioequivalencePharmacology030226 pharmacology & pharmacyDosage formPermeabilityBiopharmaceuticsExcipients03 medical and health sciences0302 clinical medicineFolic AcidPharmacokineticsCell Line TumorHumansSolubilityActive ingredientDosage FormsChemistryBiopharmaceutics Classification SystemBioavailabilityFolic acidSolubilityTherapeutic Equivalency030220 oncology & carcinogenesisCaco-2 CellsJournal of pharmaceutical sciences
researchProduct